26 Nov 2024
A dedicated TAVI valve for aortic regurgitation: the J-VALVE solution
Sponsored by Genesis MedTech
Anchorperson:
S. C. C. Lam
Summary
Discover the 30-day outcomes of the novel transfemoral J-VALVE solution, a dedicated TAVI device designed specifically for the treatment of aortic regurgitation. Understand its unique automatic anchoring mechanism and the remarkable left ventricular remodelling it can facilitate.
Learning Objectives
- To learn the 30-day outcomes of a novel TAVI device for aortic regurgitation
- To learn how a novel TAVI device with automatic anchoring mechanism for aortic regurgitation works
- To learn how left ventricular remodeling happens in aortic regurgitation after implantation of a novel TAVI device for aortic regurgitation
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide015.jpg)
/slide016.jpg)
/slide017.jpg)
/slide018.jpg)
/slide019.jpg)
/slide020.jpg)
/slide021.jpg)
/slide022.jpg)
/slide023.jpg)
/slide024.jpg)
/slide025.jpg)
/slide026.jpg)
/slide027.jpg)
/slide028.jpg)
/slide029.jpg)